Companies: 10,795·Total market cap: $144.5T
Verastem, Inc.

Verastem, Inc.

VSTMNASDAQHealthcare● Active
$3.69
$-0.03(-0.67%)
Market Cap$255421725
P/E Ratio—
52W High$11.25
52W Low$3.58
SEC Filings

Verastem, Inc. (VSTM) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001526119 · VSTM · NASDAQ · as of Jun 8, 2026

Filing snapshot

1,014+
Total Filings
S-8
Latest Form
2026-05-29
Most Recent
2012
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001526119 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-04
Fiscal Year End
Mar 4, 2026
Accession No.
0001104659-26-023444
Primary Document
vstm-20251231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001526119 · Accession 0001104659-26-023444

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-26Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
S-8Employee Stock Plan Registration
FORM S-8
2026-05-29
View
3Initial Statement of Beneficial Ownership
OWNERSHIP DOCUMENT
2026-05-27
View
8-KCurrent Report
8-K
2026-05-26
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
8-KCurrent Report
FORM 8-K
2026-05-07
View
10-QQuarterly Report
10-Q
2026-05-07
View
DEF 14AProxy Statement
DEF 14A
2026-04-09
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-27
View
8-KCurrent Report
FORM 8-K
2026-03-04
View
10-KAnnual Report
10-K
2026-03-04
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
Showing 1–15 of 541 filingsForm 4 / 144 hidden· 1014 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001526119  |  Exchange: NASDAQ · Healthcare

Verastem, Inc. (NASDAQ: VSTM) has submitted 1,014+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2012. As a Healthcare sector company with CIK 0001526119, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Verastem, Inc.'s most comprehensive regulatory disclosure. The most recent Verastem, Inc. 10-K was filed on 2026-03-04 for fiscal year ending 2026. Historical VSTM 10-K annual reports are available from 2012 through 2026.

Investors researching Verastem, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
KALV SEC Filings →MLTX SEC Filings →ABSI SEC Filings →VTYX SEC Filings →CRVS SEC Filings →OLMA SEC Filings →FDMT SEC Filings →PRTA SEC Filings →
→ VSTM Financials→ VSTM Earnings→ VSTM Insider Trades

Frequently Asked Questions

VSTM SEC Filings · 8 questions

Verastem, Inc. (VSTM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,014+ filings and access original documents at no cost. Verastem, Inc.'s CIK is 0001526119.

VSTM SEC filingsVerastem, Inc. SEC documentsfind VSTM 10-K